ERYTHROPOIETIN IN THE TREATMENT OF THE ANEMIA OF CHRONIC RENAL-FAILURE

被引：0
作者：
WINEARLS, CG
机构：
来源：
INTERNATIONAL YEARBOOK OF NEPHROLOGY | 1989年
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：263 / 277
页数：15
相关论文
共 47 条
[1]  
ALTMANN P, 1988, LANCET, V1, P1012
[2]  
Bocker A, 1988, Contrib Nephrol, V66, P165
[3]  
Bommer J, 1988, Contrib Nephrol, V66, P131
[4]  
BOMMER J, 1987, Nephrology Dialysis Transplantation, V2, P238
[5]  
Bommer J, 1988, Contrib Nephrol, V66, P85
[6]  
Caro J, 1988, Contrib Nephrol, V66, P54
[7]   BENEFITS AND RISKS OF PROTRACTED TREATMENT WITH HUMAN RECOMBINANT ERYTHROPOIETIN IN PATIENTS HAVING HEMODIALYSIS [J].
CASATI, S ;
PASSERINI, P ;
CAMPISE, MR ;
GRAZIANI, G ;
CESANA, B ;
PERISIC, M ;
PONTICELLI, C .
BMJ-BRITISH MEDICAL JOURNAL, 1987, 295 (6605) :1017-1020
[8]   SERUM IMMUNOREACTIVE ERYTHROPOIETIN LEVELS IN PATIENTS WITH POLYCYSTIC KIDNEY-DISEASE AS COMPARED WITH OTHER HEMODIALYSIS-PATIENTS [J].
CHANDRA, M ;
MILLER, ME ;
GARCIA, JF ;
MOSSEY, RT ;
MCVICAR, M .
NEPHRON, 1985, 39 (01) :26-29
[9]  
COTES PM, 1987, EXP HEMATOL, V15, P437
[10]  
COTES PM, UNPUB CHARACTERISATI
12345